BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1866205)

  • 1. [Utility of morphometry and nucleolar organizer regions count in the differentiation of reactive and malignant mesothelial cells in pleural effusions].
    Colecchia M; Agnelli T; Caronni E; Leopardi O
    Pathologica; 1991; 83(1083):89-97. PubMed ID: 1866205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of AgNOR count in distinguishing benign from malignant mesothelial cells in pleural fluids.
    Colecchia M; Leopardi O
    Pathol Res Pract; 1992 Jun; 188(4-5):541-4. PubMed ID: 1409085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on diagnostic value of analyzing argyrophilic nucleolar organizer regions in benign and malignant pleural effusions].
    Jiang S; Zeng Z; Liao Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):34-6. PubMed ID: 11263298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
    Mohanty SK; Dey P; Rana P
    Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of AgNOR technique in the interpretation of serous effusions].
    Rocher AE; Blanco AM; Palaoro LA
    Rev Med Chil; 2000 Sep; 128(9):963-8. PubMed ID: 11349500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions in mesothelial proliferations.
    Ramael M; Van den Bossche J; Buysse C; Van Marck E
    J Pathol; 1992 Aug; 167(4):435. PubMed ID: 1403363
    [No Abstract]   [Full Text] [Related]  

  • 7. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of silver-stained interphase nucleolar organizer regions as a parameter to distinguish neoplastic from nonneoplastic reactive cells in human effusions.
    Derenzini M; Nardi F; Farabegoli F; Ottinetti A; Roncaroli F; Bussolati G
    Acta Cytol; 1989; 33(4):491-8. PubMed ID: 2473585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions.
    Vacharadze K; Burkadze G; Turashvili G; Kiria N
    Georgian Med News; 2005 Nov; (128):91-3. PubMed ID: 16369075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
    Wolanski KD; Whitaker D; Shilkin KB; Henderson DW
    Cancer; 1998 Feb; 82(3):583-90. PubMed ID: 9452278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
    Cakir E; Demirag F; Aydin M; Unsal E
    Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy.
    Lim SM; Duggan MA; Ruff M; Rahim S; McGregor SE; Green FH
    J Pathol; 1992 Jan; 166(1):53-60. PubMed ID: 1538274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of nucleoli and nucleolar organizer regions in cultured primary human normal, reactive and malignant mesothelial cells.
    Ribotta M; Donna A; Betta PG; Libener R; Bellingeri D; Robutti F
    Pathol Res Pract; 1992 Jun; 188(4-5):536-40. PubMed ID: 1409084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric study on the nucleoli of mesothelial and tumour cells being in pleural cavity effusions.
    Valkov I; Topov J; Glukhchev G; Marinov M
    Arch Geschwulstforsch; 1977; 47(3):220-5. PubMed ID: 71882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
    Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
    Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of AgNOR technique in distinguishing reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
    Ramesh K; Gahukamble L; al Fituri O
    Cent Afr J Med; 1994 Sep; 40(9):265. PubMed ID: 7834719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.